VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ZNTL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ZNTLZentalis Pharmaceuticals, Inc.
$1.36$97M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksZNTLQuarterly Financials

Zentalis Pharmaceuticals, Inc. (ZNTL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Zentalis Pharmaceuticals, Inc. (ZNTL) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ZNTL Income Statement

Quarterly statement

ZNTL Income Statement

Zentalis Pharmaceuticals, Inc. (ZNTL) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue000000026.86M0040.56M000000000
Revenue Growth %----100%---100%-------------
Cost of Goods Sold00151K0000000324K000000000
COGS % of Revenue----------0.8%---------
Gross Profit00-151K000026.86M0040.24M000000000
Gross Margin %-------100%--99.2%---------
Gross Profit Growth %----100%---100%-------------
Operating Expenses31.15M44.39M37.7M37.39M33.73M36.06M45.62M76.71M51.43M65.15M65M67.92M62.72M103.92M64.95M51.75M54.19M63.46M57.88M48.19M
OpEx % of Revenue-------285.55%--160.26%---------
Selling, General & Admin8.82M9.23M8.99M7.91M10.78M7.3M10.58M40.01M14.61M16.76M15.42M16.36M15.95M15.66M16.37M11.14M12.01M19.64M11.77M9.75M
SG&A % of Revenue-------148.91%--38.01%---------
Research & Development22.33M35.16M28.72M29.49M22.95M27.61M27.25M32.97M36.82M48.39M49.59M51.56M46.77M42.68M48.58M40.62M42.18M43.83M46.11M38.44M
R&D % of Revenue-------122.74%--122.25%---------
Other Operating Expenses000001000K1000K1000K0-10101000K000000
Operating Income-31.15M-44.39M-37.85M-37.39M-33.73M-36.06M-45.62M-49.85M-51.43M-65.15M-24.77M-67.92M-62.72M-103.92M-64.95M-51.75M-54.19M-63.46M-57.88M-48.19M
Operating Margin %--------185.55%---61.06%---------
Operating Income Growth %7.65%-23.11%17.03%24.99%34.41%44.65%-84.22%26.61%17.99%37.31%61.87%-31.24%-15.73%-63.75%-12.22%-7.39%13.8%-15.11%-14.96%-19.75%
EBITDA-31M-44.24M-37.7M-37.24M-33.57M-35.9M-45.36M-49.53M-51.11M-64.82M-24.44M-67.58M-62.37M-103.57M-64.59M-51.4M-53.82M-63.11M-57.53M-47.98M
EBITDA Margin %--------184.37%---60.26%---------
EBITDA Growth %7.66%-23.23%16.88%24.82%34.31%44.62%-85.59%26.71%18.05%37.41%62.16%-31.5%-15.89%-64.11%-12.27%-7.11%14.21%-14.72%-14.46%-19.33%
D&A (Non-Cash Add-back)152K153K151K157K160K160K262K317K321K327K324K337K348K344K360K359K375K348K344K209K
EBIT-28.7M-42.15M-35.23M-34.77M-26.69M-34.91M-37.83M-46.11M-40.19M-88.01M10.18M-61.07M-62.72M-58.35M-64.95M-51.75M-54.19M-63.46M-57.88M-38.19M
Net Interest Income000000000000000-344.51K0000
Interest Income0000000000000004930000
Interest Expense000000000000000345K0000
Other Income/Expense2.46M2.24M2.62M2.62M7.04M9.18M-2.66M2.17M11.25M-22.86M34.95M6.85M7.21M-9.25M1.8M-3.59M-466K-4.91M-1.32M-1.74M
Pretax Income-28.7M-42.15M-35.23M-34.77M-26.69M-26.87M-48.28M-47.68M-40.19M-88.01M10.18M-61.07M-55.51M-113.17M-63.15M-55.34M-54.66M-68.38M-59.2M-49.94M
Pretax Margin %--------177.47%--25.11%---------
Income Tax118K138K120K442K000-205K-27K266K143K-135K31K-605K108K-360K-159K17K33K159K
Effective Tax Rate %-0.41%-0.33%-0.34%-1.27%0%0%0%0.43%0.07%-0.3%1.4%0.22%-0.06%0.53%-0.17%0.65%0.29%-0.02%-0.06%-0.32%
Net Income-28.82M-42.29M-35.35M-35.22M-26.69M-26.87M-48.28M-47.47M-40.16M-88.28M10.07M-60.92M-55.53M-112.53M-63.22M-54.97M-54.4M-68.36M-59.08M-50.06M
Net Margin %--------176.71%--24.82%---------
Net Income Growth %-7.96%-57.35%26.78%25.82%33.53%69.56%-579.53%22.07%27.68%21.55%115.93%-10.82%-2.07%-64.62%-7.01%-9.81%-1198.04%-25.26%-18.39%-24.21%
Net Income (Continuing)-28.82M-42.29M-35.35M-35.22M-26.69M-26.87M-48.28M-47.47M-40.16M-88.28M10.04M-60.94M-55.54M-112.56M-63.26M-54.98M-54.5M-68.39M-59.24M-50.09M
Discontinued Operations00000000000000000000
Minority Interest00000000000107K129K141K178K221K234K333K368K528K
EPS (Diluted)-0.34-0.59-0.50-0.49-0.37-0.37-0.67-0.67-0.56-1.240.14-0.86-0.79-1.85-1.03-0.81-0.92-1.23-1.27-1.11
EPS Growth %8.11%-59.46%25.37%26.87%33.93%70.16%-578.57%22.09%29.11%32.97%113.59%-6.17%14.13%-50.41%18.9%27.03%-879.77%8.21%-2.42%-9.9%
EPS (Basic)-0.34-0.59-0.50-0.49-0.37-0.37-0.67-0.67-0.56-1.240.14-0.86-0.79-1.85-1.03-0.81-0.92-1.23-1.27-1.11
Diluted Shares Outstanding84.61M71.33M70.26M71.67M72.14M71.99M71.68M71.24M71.11M71.04M71.19M70.77M70.61M60.79M59.28M59.28M56.81M51.12M45.24M44.98M
Basic Shares Outstanding84.61M71.33M70.26M71.67M72.14M71.99M71.68M71.24M71.11M71.04M70.9M70.77M70.61M60.79M59.28M59.28M56.81M51.12M45.24M44.98M
Dividend Payout Ratio--------------------